Rumker, Laurie
Sakaue, Saori http://orcid.org/0000-0003-3618-9717
Reshef, Yakir
Kang, Joyce B.
Yazar, Seyhan
Alquicira-Hernandez, Jose
Valencia, Cristian
Lagattuta, Kaitlyn A.
Mah-Som, Annelise
Nathan, Aparna http://orcid.org/0000-0002-5975-2851
Powell, Joseph E. http://orcid.org/0000-0002-5070-4124
Loh, Po-Ru http://orcid.org/0000-0001-5542-9064
Raychaudhuri, Soumya http://orcid.org/0000-0002-1901-8265
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (F30AI157385, F30AI172238, P01AI148102)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM144273, T32HG002295)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (T32HG01046, U01HG012009, R56HG013083)
Department of Health | National Health and Medical Research Council (2018432, 1175781)
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR063759, UC2AR081023)
PRL is supported by a Burroughs Wellcome Fund Career Award at the Scientific Interfaces. JEP is also supported by a fellowship from the Fok Foundation.
Article History
Received: 10 November 2023
Accepted: 14 August 2024
First Online: 26 September 2024
Competing interests
: S.R. is a founder for Mestag Therapeutics and a scientific advisor for Janssen, Sonoma and Pfizer. J.E.P. is a founder of CellTellus Laboratory. The other authors declare no competing interests.